Literature DB >> 25583048

Human native, enzymatically modified and oxidized low density lipoproteins show different lipidomic pattern.

Evelyn Orsó1, Silke Matysik1, Margot Grandl1, Gerhard Liebisch1, Gerd Schmitz2.   

Abstract

In the present paper we have performed comparative lipidomic analysis of two prototypic atherogenic LDL modifications, oxidized LDL and enzymatically modified LDL. Oxidization of LDL was carried out with different chemical modifications starting from the same native LDL preparations: (i) by copper oxidation leading to terminally oxidized LDL (oxLDL), (ii) by moderate oxidization with HOCl (HOCl LDL), (iii) by long term storage of LDL at 4°C to produce minimally modified LDL (mmLDL), or (iv) by 15-lipoxygenase, produced by a transfected fibroblast cell line (LipoxLDL). The enzymatic modification of LDL was performed by treatment of native LDL with trypsin and cholesteryl esterase (eLDL). Free cholesterol (FC) and cholesteryl esters (CE) represent the predominant lipid classes in all LDL preparations. In contrast to native LDL, which contains about two-thirds of total cholesterol as CE, enzymatic modification of LDL decreased the proportion of CE to about one-third. Free cholesterol and CE in oxLDL are reduced by their conversion to oxysterols. Oxidization of LDL preferentially influences the content of polyunsaturated phosphatidylcholine (PC) and polyunsaturated plasmalogen species, by reducing the total PC fraction in oxLDL. Concomitantly, a strong rise of the lysophosphatidylcholine (LPC) fraction can be found in oxLDL as compared to native LDL. This effect is less pronounced in eLDL. The mild oxidation of LDL with hypochlorite and/or lipoxygenase does not alter the content of the analyzed lipid classes and species in a significant manner. The lipidomic characterization of modified LDLs contributes to the better understanding their diverse cellular effects.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Low density lipoproteins; Oxysterols; Phospholipids; eLDL; oxLDL

Mesh:

Substances:

Year:  2015        PMID: 25583048     DOI: 10.1016/j.bbalip.2015.01.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  oxLDL and eLDL Induced Membrane Microdomains in Human Macrophages.

Authors:  Stefan Wallner; Margot Grandl; Gerhard Liebisch; Markus Peer; Evelyn Orsó; Alexander Sigrüner; Andrzej Sobota; Gerd Schmitz
Journal:  PLoS One       Date:  2016-11-21       Impact factor: 3.240

Review 2.  An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases.

Authors:  Shi-Hui Law; Mei-Lin Chan; Gopal K Marathe; Farzana Parveen; Chu-Huang Chen; Liang-Yin Ke
Journal:  Int J Mol Sci       Date:  2019-03-06       Impact factor: 5.923

3.  Maternal obesity alters placental lysophosphatidylcholines, lipid storage, and the expression of genes associated with lipid metabolism‡.

Authors:  Katie L Bidne; Alana L Rister; Andrea R McCain; Brianna D Hitt; Eric D Dodds; Jennifer R Wood
Journal:  Biol Reprod       Date:  2021-01-04       Impact factor: 4.161

4.  Phosphatidylcholine and phosphatidylethanolamine plasmalogens in lipid loaded human macrophages.

Authors:  Stefan Wallner; Evelyn Orsó; Margot Grandl; Tatiana Konovalova; Gerhard Liebisch; Gerd Schmitz
Journal:  PLoS One       Date:  2018-10-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.